You are here

  • Home
  • Archive
  • Volume 27, Issue 3
  • PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes

Article info

Article menu
Download PDFPDF
Trophoblastic Disease
PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes

Authors

  • Pierre-Adrien Bolze Department of Gynecological Surgery and Oncology, Obstetrics, andFrench Center for Trophoblastic Diseases, University Hospitals of Lyon; andJoint Unit Hospices Civils de Lyon-bioMerieux, University Hospital Lyon Sud, Pierre Bénite; PubMed articlesGoogle scholar articles
  • Sophie Patrier Joint Unit Hospices Civils de Lyon-bioMerieux, University Hospital Lyon Sud, Pierre Bénite;Department of Pathology, University Hospital of Rouen, Rouen; PubMed articlesGoogle scholar articles
  • Jérôme Massardier French Center for Trophoblastic Diseases, University Hospitals of Lyon; andUniversity Hospital Femme Mere Enfant, Department of Prenatal Diagnosis; and PubMed articlesGoogle scholar articles
  • Touria Hajri French Center for Trophoblastic Diseases, University Hospitals of Lyon; andPôle Information Médicale Evaluation Recherche, Hospices Civils de Lyon, Bron; and PubMed articlesGoogle scholar articles
  • Fatima Abbas French Center for Trophoblastic Diseases, University Hospitals of Lyon; andPôle Information Médicale Evaluation Recherche, Hospices Civils de Lyon, Bron; and PubMed articlesGoogle scholar articles
  • Anne Marie Schott French Center for Trophoblastic Diseases, University Hospitals of Lyon; andPôle Information Médicale Evaluation Recherche, Hospices Civils de Lyon, Bron; and PubMed articlesGoogle scholar articles
  • Fabienne Allias French Center for Trophoblastic Diseases, University Hospitals of Lyon; andDepartment of Pathology, University Hospital La Croix Rousse; PubMed articlesGoogle scholar articles
  • Mojgan Devouassoux-Shisheboran French Center for Trophoblastic Diseases, University Hospitals of Lyon; andDepartment of Pathology, University Hospital La Croix Rousse; PubMed articlesGoogle scholar articles
  • Gilles Freyer French Center for Trophoblastic Diseases, University Hospitals of Lyon; andDepartment of Medical Oncology, HCL Cancer Institute, University Hospitals of Lyon; and PubMed articlesGoogle scholar articles
  • François Golfier Department of Gynecological Surgery and Oncology, Obstetrics, andFrench Center for Trophoblastic Diseases, University Hospitals of Lyon; and PubMed articlesGoogle scholar articles
  • Benoît You French Center for Trophoblastic Diseases, University Hospitals of Lyon; andDepartment of Medical Oncology, HCL Cancer Institute, University Hospitals of Lyon; andLyon 1 University, Lyon, France. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Pierre-Adrien Bolze, MD, French Center for Trophoblastic Diseases, University Hospitals of Lyon, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, Bâtiment 3B, 2ème étage, 69495 Pierre Bénite, France. E-mail: pierre-adrien.bolze@chu-lyon.fr.

Citation

Bolze P, Patrier S, Massardier J, et al
PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes
International Journal of Gynecologic Cancer 2017;27:554-561.

Publication history

  • Received September 5, 2016
  • First published March 1, 2017.
Online issue publication 
March 01, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2017 by IGCS and ESGO